Early Access — free while we kick the tires
EdgarHawk

DANIELS RONALD J

Director

Director
1 filing analyzed · 1 company · Latest 2025-11-07

Companies

Company Buys Sells Direction
BridgeBio Pharma, Inc. BBIO 0 2 Net selling

Activity

November 2025
2025-11-07 BridgeBio Pharma, Inc. BBIO
high
Sell
61,031 shares
$3,888,999
Significance 7/10

Director Ronald J. Daniels sold 61,031 shares of BBIO at $63.72 for $3.9M, retaining 16,991 shares (-78.2% of holdings).

Ronald J. Daniels divested the majority of his BBIO position, reducing holdings from 78,022 shares to 16,991 shares via a single $3.9M sale at $63.72 per share. This large-scale reduction occurred while the stock sits 7.2% below its 52-week high of $66.62 and near recent multi-year trading levels, within a context of exceptional revenue growth (annual growth +2285.3%) but persistent unprofitability (net income of $-184.9M in the latest full fiscal year). The near-complete liquidation of a director's position warrants investor scrutiny of the factors driving such a substantial departure from the stock.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access